Vinblastine
Top View
- CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS
- Crystal and Molecularstructure of Paclitaxel (Taxol)
- 2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
- Vinorelbine Is a Semi-Synthetic Vinca-Alkaloid with a Broad Spec- Molecular Mechanisms of Action Trum of Anti-Tumour Activity
- Estramustine Depolymerizes Microtnbules by Binding to Tubulin 1
- Abdominal Desmoid Tumors with Chemotherapy
- Supplementary Oral Anamorelin Mitigates Anorexia and Skeletal Muscle Atrophy Induced by Gemcitabine Plus Cisplatin Systemic Chemotherapy in a Mouse Model
- 2019 Table of Drugs
- Vinblastine Ver
- Drug-Induced Stimulation of Nitrogen Mustard and Choline Transport and Other Systems in L5178Y Lymphoblasts in Vitro1
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- Clinically Relevant Concentrations of Anticancer Drugs: a Guide for Nonclinical Studies Dane R
- Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer
- Randomized Phase II Trial Assessing Estramustine and Vinblastine
- Therapeutic Anticancer Efficacy of a Synthetic Diazonamide Analog in the Absence of Overt Toxicity
- Longitudinal Trends in Use and Costs of Targeted Therapies for Common Cancers in Taiwan: a Retrospective Observational Study
- LUNG CANCER TREATMENT REGIMENS (Part 1 of 7) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
- Handling Cytostatic Drugs: Contents